Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Annals of Surgical Oncology
Published in: Annals of Surgical Oncology 5/2014

01-05-2014 | Regional Cancer Therapies

Regional Therapies for Advanced Cancer

Authors: K. K. Turaga, T. C. Gamblin, MD, MS

Published in: Annals of Surgical Oncology | Issue 5/2014

Login to get access

Excerpt

Regional therapies for advanced malignancies have evolved from being merely anatomically targeted therapies to individualized therapies that are evidence based and discerning of the patients who would derive the most benefit. Pursuits of precise surgical technique, as well as advances in anesthesia and systemic therapies, have allowed the application of these therapies in new frontiers. …
Literature
1.
Kwa M, Muggia F. Ovarian cancer: a brief historical overview of intraperitoneal trials. Ann Surg Oncol. In press.
2.
Speicher PJ, et al. Hypoxia in melanoma: using optical spectroscopy and EF5 to assess tumor oxygenation before and during regional chemotherapy for melanoma. Ann Surg Oncol. In press.
3.
Lohani K, et al. Pseudomyxoma peritonei: inflammatory responses in the peritoneal microenvironment. Ann Surg Oncol. In press.
4.
Magge D, et al. Aggressive locoregional surgical therapy for gastric peritoneal carcinomatosis. Ann Surg Oncol. In press.
5.
Yang XJ, et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy improves survival of patients with peritoneal carcinomatosis from gastric cancer: final results of a phase III randomized clinical trial. Ann Surg Oncol. 2011;18:1575–81.PubMedCentralPubMedCrossRef
6.
Winer J, et al. Impact of aggressive histology and location of primary tumor on the efficacy of surgical therapy for peritoneal carcinomatosis of colorectal origin. Ann Surg Oncol. In press.
7.
McPartland SJ, Goodman MD. The effect of elevated body mass index on outcomes following cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol. In press.
8.
Kwa M, et al. Ovarian cancer in BRCA mutation carriers: improved outcome after intraperitoneal (IP) cisplatin. Ann Surg Oncol. In press.
9.
Wong J, et al. Resection of residual disease after isolated limb infusion (ILI) is equivalent to a complete response after ILI-alone in advanced extremity melanoma. Ann Surg Oncol. In press.
10.
Randle RW, et al. Efficacy of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in the management of malignant ascites. Ann Surg Oncol. In press.
11.
Wong J, et al. Repeat cytoreductive surgery and heated intraperitoneal chemotherapy may offer survival benefit for intraperitoneal mesothelioma: a single institution experience. Ann Surg Oncol. In press.
12.
Owusu-Agyemang P, et al. Safety of epidural analgesia in the perioperative care of patients undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol. In press.
13.
Bartlett EK, et al. Morbidity and mortality of cytoreduction with intraperitoneal chemotherapy: outcomes from the ACS NSQIP Database. Ann Surg Oncol. In press.
14.
Turaga K, et al. Consensus guidelines from the American Society of Peritoneal Surface Malignancies on Standardizing the Delivery of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in colorectal cancer patients in the United States. Ann Surg Oncol. In press.
Metadata
Title
Regional Therapies for Advanced Cancer
Authors
K. K. Turaga
T. C. Gamblin, MD, MS
Publication date
01-05-2014
Publisher
Springer US
Published in
Annals of Surgical Oncology / Issue 5/2014
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-014-3496-x

Other articles of this Issue 5/2014

Annals of Surgical Oncology 5/2014 Go to the issue

Original Article -– Regional Cancer Therapies

Safety of Epidural Analgesia in the Perioperative Care of Patients Undergoing Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy

Colorectal Cancer

Bevacizumab Efficacy in Metastatic Colorectal Cancer is Dependent on Primary Tumor Resection

Regional Cancer Therapies

Hypoxia in Melanoma: Using Optical Spectroscopy and EF5 to Assess Tumor Oxygenation Before and During Regional Chemotherapy for Melanoma

Healthcare Policy and Outcomes

In Memoriam: Donald L. Morton, MD (1934–2014): An Icon in Surgical Oncology

Regional Cancer Therapies

Impact of Aggressive Histology and Location of Primary Tumor on the Efficacy of Surgical Therapy for Peritoneal Carcinomatosis of Colorectal Origin

Healthcare Policy and Outcomes

The End of the Beginning: Society of Surgical Oncology 2013 Presidential Address